Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature

被引：0
|
作者：
M. Opdam
V. van der Noort
M. Kleijn
A. Glas
I. Mandjes
S. Kleiterp
F. S. Hilbers
D. T. Kruger
A. D. Bins
P. C. de Jong
P. P. J. B. M. Schiphorst
T. van Dalen
B. Flameling
R. C. Rietbroek
A. Beeker
S. M. van den Heiligenberg
S. D. Bakker
A. N. M. Wymenga
I. M. Oving
R. M. Bijlsma
P. J. van Diest
J. B. Vermorken
H. van Tinteren
S. C. Linn
机构：
[1] Netherlands Cancer Institute,Department of Molecular Pathology
[2] Netherlands Cancer Institute,Biometrics Department
[3] Agendia NV,Medical Affairs
[4] Amsterdam UMC,Department of Medical Oncology
[5] Sint-Antonius Hospital,Department of Medical Oncology
[6] Streekziekenhuis Koningin. Beatrix,Department of Internal Medicine
[7] Diakonessenhuis,Department of Surgery
[8] OLVG,Department of Medical Oncology
[9] Red Cross Hospital,Department of Internal Medicine
[10] Spaarne Gasthuis,Department of Medical Oncology
[11] Dijklander Ziekenhuis,Department of Medical Oncology
[12] Zaans Medisch Centrum,Department of Internal Medicine
[13] Medisch Spectrum Twente,Department of Medical Oncology
[14] Ziekenhuisgroep Twente,Department of Medical Oncology
[15] UMCU,Department of Medical Oncology
[16] UMCU,Department of Pathology
[17] University Hospital Antwerp (UZA),Department of Medical Oncology
[18] University of Antwerp,Faculty of Medicine and Health Sciences
[19] Trial and Data Center,Department of Medical Oncology
[20] Princess Maxima Centre for Pediatric Oncology,undefined
[21] Netherlands Cancer Institute,undefined
来源：
Breast Cancer Research and Treatment | 2022年 / 194卷
关键词：
Early breast cancer; Postmenopausal; MammaPrint 70-gene signature; Prognosis; Endocrine treatment; Overtreatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：265 / 278
页数：13
相关论文
共 50 条
  • [1] Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature
    Opdam, M.
    van der Noort, V
    Kleijn, M.
    Glas, A.
    Mandjes, I
    Kleiterp, S.
    Hilbers, F. S.
    Kruger, D. T.
    Bins, A. D.
    de Jong, P. C.
    Schiphorst, P. P. J. B. M.
    van Dalen, T.
    Flameling, B.
    Rietbroek, R. C.
    Beeker, A.
    van den Heiligenberg, S. M.
    Bakker, S. D.
    Wymenga, A. N. M.
    Oving, I. M.
    Bijlsma, R. M.
    van Diest, P. J.
    Vermorken, J. B.
    van Tinteren, H.
    Linn, S. C.
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 194 (02) : 265 - 278
  • [2] 70-gene signature to select breast cancer patients for neoadjuvant endocrine treatment
    Jacobs, C. F.
    Bartels, S. A. L.
    Loo, C. E.
    Smorenburg, C.
    Linn, S.
    Wesseling, J.
    van Duijnhoven, F.
    Kok, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S322 - S323
  • [3] Avoid systemic overtreatment of postmenopausal breast cancer patients with ultralow MammaPrint result
    Opdam, M.
    van der Noort, V.
    Kleijn, M.
    Glas, A.
    Mandjes, I.
    Kruger, D.
    van Diest, P.
    Vermorken, J. B.
    van Tinteren, H.
    Linn, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S310 - S310
  • [4] The 70-Gene Prognostic Signature for Korean Breast Cancer Patients
    Na, Kuk Young
    Kim, Ku Sang
    Lee, Jeong Eon
    Kim, Hee Jeong
    Yang, Jung-Hyun
    Ahn, Sei-Hyun
    Moon, Byung-In
    Kim, Ra Mi
    Ko, Si Mon
    Jung, Yong Sik
    JOURNAL OF BREAST CANCER, 2011, 14 (01) : 33 - 38
  • [5] The 70-gene MammaPrint signature for optimal risk stratification in endocrine responsive breast cancer
    Knauer, M.
    Rutgers, E.
    Mook, S.
    Cardoso, F.
    van de Vijver, M.
    Viale, G.
    Glas, A.
    Saghatchian, M.
    Kok, M.
    Bueno-de-Mesquita, J.
    Linn, S.
    van 't Veer, L.
    BREAST, 2009, 18 : S36 - S36
  • [6] 20-year benefit of endocrine therapy in premenopausal breast cancer patients by the 70-gene risk signature
    Johansson, A.
    Dar, H.
    Van'T Veer, L.
    Perez-Tenorio, G.
    Nordenskjold, A.
    Yau, C.
    Benz, C.
    Esserman, L.
    Stal, O.
    Nordenskjold, B.
    Fornander, T.
    Lindstrom, L.
    ANNALS OF ONCOLOGY, 2021, 32 : S21 - S21
  • [7] Outcome of patients with an ultralow risk 70-gene signature in the MINDACT trial.
    Cardozo, Josephine Lopes
    Drukker, Caroline
    Schmidt, Marjanka
    van't Veer, Laura
    Glas, Annuska
    Witteveen, Anke
    Cardoso, Fatima
    Piccart-Gebhart, Martine J.
    Poncet, Coralie
    Rutgers, Emiel J.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] Outcome of Patients With an Ultralow-Risk 70-Gene Signature in the MINDACT Trial
    Cardozo, Josephine M. N. Lopes
    Drukker, Caroline A.
    Rutgers, Emiel J. T.
    Schmidt, Marjanka K.
    Glas, Annuska M.
    Witteveen, Anke
    Cardoso, Fatima
    Piccart, Martine
    Esserman, Laura J.
    Poncet, Coralie
    van't Veer, Laura J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (12) : 1335 - +
  • [9] 70-Gene Signature in Early-Stage Breast Cancer
    Blok, Erik J.
    van de Velde, Cornelis J.
    Smit, Vincent T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (22): : 2199 - 2199
  • [10] The 70-gene prognosis profile predicts early metastases in postmenopausal breast cancer patients
    Mook, S.
    Schmidt, M. K.
    Weigelt, B.
    Kreike, B.
    Eekhout, I
    Glas, A. M.
    Floore, A. N.
    Rutgers, E. J.
    Van 't Veer, L. J.
    CANCER RESEARCH, 2009, 69 (02) : 124S - 124S
12345